Review of the neuroprotective role of vitamin D in traumatic brain injury

doi:10.3877/cma.j.issn.2095-9141.2017.03.012

Abstract

Abstract:

Traumatic brain injury (TBI), one of the most common diseases of neurosurgery, remains high mortality and disability in the population under 45 years. TBI patients suffer permanent cognitive neurological and psychological disabilities. In recent years, basic and clinical experiments have shown that the active form of vitamin D3 (vitamin D hormone, VDH) treatment can improve TBI-induced cognitive impairment and mental disorders. Therefore, in this paper, we focused on the physiological role of vitamin D and the possible mechanism of VDH supplementation following TBI.

Key words: Vitamin D, Traumatic brain injury, Treatment

Changmeng Cui, Xin Guo, Sixin Song, Zhengang Liu, Pei Jiang. Review of the neuroprotective role of vitamin D in traumatic brain injury[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2017, 03(03): 175-178.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsjcswkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9141.2017.03.012

https://zhsjcswkdzzz.cma-cmc.com.cn/EN/Y2017/V03/I03/175

References 35

[1]	Davis T, Ings A; National Institute of Health and Care Excellence. Head injury: triage, assessment, investigation and early management of head injury in children, young people and adults (NICE guideline CG 176)[J]. Arch Dis Child Educ Pract Ed, 2015, 100(2): 97-100.
[2]	Titus DJ, Wilson NM, Freund JE, et al. Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor[J]. J Neurosci, 2016, 36(27): 7095-7108.
[3]	Han K, Chapman SB, Krawczyk DC. Altered Amygdala Connectivity in Individuals with Chronic Traumatic Brain Injury and Comorbid Depressive Symptoms[J]. Front Neurol, 2015, 6: 231.
[4]	Kim J, Lee Y, Kye S, et al. Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008-2010[J]. J Cachexia Sarcopenia Muscle, 2017, 8(2): 259-266.
[5]	Chin K, Zhao D, Tibuakuu M, et al. Physical activity, Vitamin D, and Incident Atherosclerotic Cardiovascular Disease in Whites and Blacks: the ARIC Study[J]. J Clin Endocrinol Metab, 2017, 102(4): 1227-1236.
[6]	Lam V, Takechi R, Pallabage-Gamarallage M, et al. The Vitamin D, Ionised Calcium and Parathyroid Hormone Axis of Cerebral Capillary Function: Therapeutic Considerations for Vascular-Based Neurodegenerative Disorders[J]. PLoS One, 2015, 10(4): e0125504.
[7]	von Kanel R, Fardad N, Steurer N, et al. Vitamin D Deficiency and Depressive Symptomatology in Psychiatric Patients Hospitalized with a Current Depressive Episode: A Factor Analytic Study[J]. PLoS One, 2015, 10(9): e0138550.
[8]	Jamall OA, Feeney C, Zaw-Linn J, et al. Prevalence and correlates of vitamin D deficiency in adults after traumatic brain injury[J]. Clin Endocrinol (Oxf), 2016, 85(4): 636-644.
[9]	Hua F, Reiss JI, Tang H, et al. Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury[J]. Horm Behav, 2012, 61(4): 642-651.
[10]	Cheng Z, Lin J, Qian Q. Role of Vitamin D in Cognitive Function in Chronic Kidney Disease[J]. Nutrients, 2016, 8(5): 291.
[11]	de Koning EJ, van Schoor NM, Penninx BW, et al. Vitamin D supplementation to prevent depression and poor physical function in older adults: Study protocol of the D-Vitaal study, a randomized placebo-controlled clinical trial[J]. BMC Geriatr, 2015, 15(1): 151.
[12]	DeLuca GC, Kimball SM, Kolasinski J, et al. Review: The role of vitamin D in nervous system health and disease[J]. Neuropathol Appl Neurobiol, 2013, 39(5): 458-484.
[13]	Suaini NH, Zhang Y, Vuillermin PJ, et al. Immune Modulation by Vitamin D and Its Relevance to Food Allergy[J]. Nutrients, 2015, 7(8): 6088-6108.
[14]	Pilon C, Urbanet R, Williams TA, et al. 1α,25-Dihydroxyvitamin D 3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer[J]. J Steroid Biochem Mol Biol, 2013, 140: 26-33.
[15]	Miratashi Yazdi SA, Abbasi M, Miratashi Yazdi SM. Epilepsy and vitamin D: a comprehensive review of current knowledge[J]. Rev Neurosci, 2017, 28(2): 185-201.
[16]	March KM, Chen NN, Karakochuk CD, et al. Maternal vitamin D3 supplementation at 50 μg/d protects against low serum 25-hydroxyvitamin D in infants at 8 wk of age: a randomized controlled trial of 3 doses of vitamin D beginning in gestation and continued in lactation[J]. Am J Clin Nutr, 2015, 102(2): 402-410.
[17]	Reichrath J, Zouboulis CC, Vogt T, et al. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook[J]. Rev Endocr Metab Disord, 2016, 17(3): 405-417.
[18]	Yu W, Ge M, Lu S, et al. Decreased expression of vitamin D receptor may contribute to the hyperimmune status of patients with acquired aplastic anemia[J]. Eur J Haematol, 2016, 96(5): 507-516.
[19]	Zhou R, Chun RF, Lisse TS, et al. Vitamin D and alternative splicing of RNA[J]. J Steroid Biochem Mol Biol, 2015, 148: 310-317.
[20]	Stumpf WE, Sar M, Clark SA, et al. Brain target sites for 1,25-dihydroxyvitamin D3[J]. Science, 1982, 215(4538): 1403-1405.
[21]	Parviainen MT, Savolainen KE, Alhava EM, et al. 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and total 24,25-dihydroxyvitamin D in human serum[J]. Ann Clin Res, 1981, 13(1): 26-33.
[22]	Pardridge WM, Sakiyama R, Coty WA. Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier[J]. J Neurochem, 1985, 44(4): 1138-1141.
[23]	Eyles DW, Smith S, Kinobe R, et al. Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain[J]. J Chem Neuroanat, 2005, 29(1): 21-30.
[24]	Spach KM, Hayes CE. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice[J]. J Immunol, 2005, 175(6): 4119-4126.
[25]	Sedighi M, Haghnegahdar A. Role of vitamin D.sub.3 in treatment of lumbar disc herniation-pain and sensory aspects: study protocol for a randomized controlled trial[J]. Trials, 2014, 15(1): 373.
[26]	Puzianowska-Kuznicka M, Pawlik-Pachucka E, Owczarz M, et al. Small-molecule hormones: molecular mechanisms of action[J]. Int J Endocrinol, 2013, 2013(15): 601246.
[27]	Tang H, Hua F, Wang J, et al. Progesterone and vitamin D: Improvement after traumatic brain injury in middle-aged rats[J]. Horm Behav, 2013, 64(3): 527-538.
[28]	Scrimgeour AG, Condlin ML. Nutritional treatment for traumatic brain injury[J]. J Neurotrauma, 2014, 31(11): 989-999.
[29]	Yan M, Nuriding H. Reversal effect of vitamin D on different multidrug-resistant cells[J]. Genet Mol Res, 2014, 13(3): 6239-6247.
[30]	Rizvi A, Chibber S, Naseem I. Cu(II)-Vitamin D interaction leads to free radical-mediated cellular DNA damage: a novel putative mechanism for its selective cytotoxic action against malignant cells[J]. Tumor Biology, 2015, 36(3): 1695-1700.
[31]	Wu D, Raafat A, Pak E, et al. Dicer-microRNA pathway is critical for peripheral nerve regeneration and functional recovery in vivo and regenerative axonogenesis in vitro[J]. Exp Neurol, 2012, 233(1): 555-565.
[32]	Pirotta S, Kidgell DJ, Daly RM. Effects of vitamin D supplementation on neuroplasticity in older adults: a double-blinded, placebo-controlled randomised trial[J]. Osteoporos Int, 2015, 26(1): 131-140.
[33]	Tang H, Fang H, Wang J, et al. Progesterone and vitamin D combination therapy modulates inflammatory response after traumatic brain injury[J]. Brain Inj, 2015, 29(10): 1-10.
[34]	Aminmansour B, Nikbakht H, Ghorbani A, et al. Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: A randomized clinical trial with placebo group[J]. Adv Biomed Res, 2012, 1(1): 58.
[35]	Cekic M, Cutler SM, Vanlandingham JW, et al. Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats[J]. Neurobiol Aging, 2011, 32(5): 864-874.

Please choose a citation manager

Content to export